These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7333345)
41. Reliability of theophylline clearance in determining chronic oral dosage regimens. Slotfeldt ML; Johnson CE; Grambau G; Weg JG Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787 [TBL] [Abstract][Full Text] [Related]
42. Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet. Lagas M; Jonkman JH Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):424-6. PubMed ID: 4044074 [TBL] [Abstract][Full Text] [Related]
43. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II. Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632 [TBL] [Abstract][Full Text] [Related]
44. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results. Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961 [TBL] [Abstract][Full Text] [Related]
45. Comparative bio-availability of theophylline whole and halved sustained-release tablets. Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of sustained release theophylline in low and high multidose regimens. Koëter GH; Jonkman JH; de Vries K; Schoenmaker R; Greving JE; de Zeeuw RA Br J Clin Pharmacol; 1981 Nov; 12(5):647-51. PubMed ID: 7332728 [TBL] [Abstract][Full Text] [Related]
47. Pharmacolinetic and pharmacodynamic data analysis of theophylline for three different drug forms. Richter O; Reinhardt D; Appel R Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):479-89. PubMed ID: 6271690 [TBL] [Abstract][Full Text] [Related]
48. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy. Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380 [TBL] [Abstract][Full Text] [Related]
49. Comparative pharmacokinetics of theophylline and aminophylline in man. Aslaksen A; Bakke OM; Vigander T Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528 [TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of a sustained-release theophylline preparation in healthy subjects. Goto M; Nakamoto Y; Sugiyama M; Yamashina H J Pharmacobiodyn; 1983 Apr; 6(4):225-31. PubMed ID: 6620110 [TBL] [Abstract][Full Text] [Related]
51. The relation of product formulation to absorption of oral theophylline. Weinberger M; Hendeles L; Bighley L N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577 [TBL] [Abstract][Full Text] [Related]
52. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations]. Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521 [TBL] [Abstract][Full Text] [Related]
53. A multiple-dose study of sustained-release theophylline and aminophylline. Meyer MC; Straughn AB; Lieberman P Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417 [TBL] [Abstract][Full Text] [Related]
54. A double-blind comparative trial between two sustained-release theophylline preparations with individual doses in asthmatic in-patients. Van der Meer YG; Van Alphen AC; Van Altena R; Van Loenen AC Pharm Weekbl Sci; 1982 Dec; 4(6):183-90. PubMed ID: 6760111 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of the Chiou method for determining theophylline dosages. Johnson MH; Burkle WS Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223 [TBL] [Abstract][Full Text] [Related]
56. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system. González MA; Straughan AB Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239 [TBL] [Abstract][Full Text] [Related]